Comparative clinical outcomes evaluation of hospitalized patients infected with Clostridioides difficile ribotype 106 vs. other toxigenic strains
Author:
Funder
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology
Reference20 articles.
1. Changes in prevalence of health care-associated infections in U.S. Hospitals;Magill;N. Engl. J. Med.,2018
2. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA);McDonald;Clin. Infect. Dis.,2018
3. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response;Vedantam;Gut Microb.,2012
4. Clostridium difficile infection: historic review;Bartlett;Anaerobe,2009
5. Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology;Martinson;J. Clin. Microbiol.,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Virulence factors, antibiotic susceptibility and sequence type distribution of hospital-associated Clostridioides difficile isolates in Israel, 2020–2022;Scientific Reports;2024-09-04
2. The Clinical Effectiveness of Fidaxomicin Compared to Vancomycin in the Treatment of Clostridioides difficile Infection, A Single-Center Real-World Experience;The Journal of Infectious Diseases;2024-05-23
3. Comparison of fidaxomicin, metronidazole and vancomycin for initial episode and recurrence of Clostridioides difficile infection - An observational cohort study;Heliyon;2024-05
4. Assessment of Knowledge and Practice of Healthcare Providers in Saudi Arabia Regarding Clostridioides difficile Infection Diagnosis and Management: A Cross-Sectional Questionnaire-Based Study;Infection and Drug Resistance;2024-02
5. ‘The Effect of Antibiotic Therapy for Clostridioides difficile Infection on Mortality and Other Patient-Relevant Outcomes’ – Author’s reply;Clinical Microbiology and Infection;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3